RUNX2 is a direct target of miR-1305 (Chen and Liu, 2017), and its up-regulation is associated with a variety of cancer tissues (Brubaker et al., 2003; Kayed et al., 2007; Endo et al., 2008). The gene discussed is RUNX2; the disease is cancer.